Mark Schoenberg
Known title: Chief Medical OfficerCIK: 0001763581
Mark Schoenberg's purchase track record
Mark Schoenberg has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2021 | URGN | $2K | -47.8% | -56.0% | -17.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| URGN | ▼ Sell | Open Market | 871 | $37K | 9/8/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,667 | — | 9/7/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 60,677 | $2.9M | 8/20/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 10,000 | $400K | 7/9/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 10,000 | $350K | 6/22/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 5,222 | $143K | 6/8/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 10,000 | — | 6/8/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 10,000 | $300K | 5/8/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 1,844 | $36K | 2/3/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 1,843 | $36K | 2/3/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 3,686 | $73K | 2/3/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 3,334 | — | 1/31/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 3,333 | — | 1/31/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 6,666 | — | 1/31/2026 | View on chart |
| URGN | ▼ Sell | Open Market | 10,000 | $250K | 11/19/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 871 | $17K | 9/8/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,667 | — | 9/7/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 10,000 | $177K | 8/11/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 10,000 | — | 7/28/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 5,149 | $99K | 7/28/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 5,162 | $38K | 6/9/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 10,000 | — | 6/8/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,334 | — | 1/31/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 759 | $8K | 1/31/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 3,333 | — | 1/31/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 1,896 | $21K | 1/31/2025 | View on chart |
| URGN | ▲ Buy | Option Exercise | 3,333 | — | 1/31/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 1,896 | $21K | 1/31/2025 | View on chart |
| URGN | ▼ Sell | Open Market | 859 | $11K | 9/9/2024 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,666 | — | 9/9/2024 | View on chart |
| URGN | ▲ Buy | Option Exercise | 10,000 | — | 6/10/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 5,153 | $67K | 6/10/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 12,000 | $169K | 3/18/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 1,894 | $30K | 1/31/2024 | View on chart |
| URGN | ▲ Buy | Option Exercise | 3,333 | — | 1/31/2024 | View on chart |
| URGN | ▲ Buy | Option Exercise | 2,000 | — | 1/31/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 1,137 | $18K | 1/31/2024 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,333 | — | 1/31/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 758 | $12K | 1/31/2024 | View on chart |
| URGN | ▼ Sell | Open Market | 991 | $10K | 1/31/2023 | View on chart |
| URGN | ▲ Buy | Option Exercise | 1,333 | — | 1/31/2023 | View on chart |
| URGN | ▼ Sell | Open Market | 661 | $7K | 1/31/2023 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 1/31/2023 | View on chart |
| URGN | ▲ Buy | Option Exercise | 2,000 | — | 1/31/2023 | View on chart |
| URGN | ▼ Sell | Open Market | 248 | $3K | 1/31/2023 | View on chart |
| URGN | ▲ Buy | Option Exercise | 122,677 | $613K | 1/20/2023 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 10/31/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 258 | $3K | 10/31/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 259 | $2K | 8/1/2022 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 7/31/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 254 | $2K | 4/30/2022 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 4/30/2022 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 1/31/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 275 | $2K | 1/31/2022 | View on chart |
| URGN | ▲ Buy | Option Exercise | 2,000 | — | 1/31/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 1,099 | $8K | 1/31/2022 | View on chart |
| URGN | ▲ Buy | Option Exercise | 209 | — | 1/26/2022 | View on chart |
| URGN | ▼ Sell | Open Market | 111 | $898 | 1/26/2022 | View on chart |
| URGN | ▲ Buy | Open Market | 160 | $2K | 11/18/2021 | View on chart |
| URGN | ▼ Sell | Open Market | 258 | $4K | 11/1/2021 | View on chart |
| URGN | ▲ Buy | Option Exercise | 500 | — | 10/31/2021 | View on chart |
| URGN | ▼ Sell | Open Market | 107 | $2K | 10/27/2021 | View on chart |
| URGN | ▲ Buy | Option Exercise | 208 | — | 10/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
UroGen Pharma highlighted as emerging GARP stock
UroGen Pharma is being discussed as an emerging GARP stock, indicating growing interest from analysts. The average target price of $60.00, with a range of $48.00 to $75.00, suggests potential upside from its current level. The stock trades near its 12‑touch support at $40.15 and has a moderate RSI of 35.3, indicating it is not overbought. These factors may influence how investors view its future performance.
UroGen Pharma highlighted as emerging GARP stock. UroGen Pharma is being discussed as an emerging GARP stock, indicating growing interest from analysts. The average target price of $60.00, with a range of $48.00 to $75.00, suggests potential upside from its current level. The stock trades near its 12‑touch support at $40.15 and has a moderate RSI of 35.3, indicating it is not overbought. These factors may influence how investors view its future performance.